Moodapex 50 mg 30 tablets

Available at Pharmaegy Pharmacy. Use as directed by your doctor.

Tradename: Mudapex Moodapex Compound: Each tablet contains: Sertraline 50 mg Properties: Antidepressant. Selective serotonin reuptake inhibitor (5-HT). It has little effect on the reuptake of norepinephrine and dopamine. At therapeutic doses, sertraline blocks the uptake of serotonin by human platelets. Sertraline has no affinity for muscarinic, serotonin, dopamine, adrenergic, histamine, GABA or benzodiazepine receptors. It does not have a stimulating, sedative or anticholinergic effect. The antidepressant effect is noted by the end of the second week of regular use of sertraline, while the maximum effect is achieved only after 6 weeks. Unlike tricyclic antidepressants, sertraline does not cause weight gain. Sertraline does not cause mental or physical drug dependence. Indications: – depression of various etiologies (treatment and prevention); – obsessive-compulsive disorders (OCD); panic disorder (with or without agoraphobia); -post-traumatic stress disorder (PTSD). Dosage and administration: For adults with depression and OCD, the drug is prescribed at an initial dose of 50 mg 1 time / day in the morning or evening. The daily dose can be gradually, not earlier than a week later, increased from 50 mg to a maximum daily dose of 200 mg. In panic disorders and PTSD, the initial dose is 25 mg 1 time / day in the morning or evening. After a week, you can increase the dose to 50 mg 1 time / day, and then gradually, not earlier than a week later, the daily dose can be increased from 50 mg to a maximum daily dose of 200 mg. A satisfactory therapeutic result is usually achieved after 7 days from the start of treatment. However, to achieve the full therapeutic effect, regular administration of the drug for 2-4 weeks is required. When treating OCD, it may take 8-12 weeks to achieve a good result. The minimum dose that provides a therapeutic effect is maintained in the future as a maintenance dose. Contraindications: -pregnancy; – lactation period; – hypersensitivity to the components of the drug; – co-administration of sertraline with tryptophan or fenfluramine. Precautionary measures: Sertraline should not be administered within 14 days after discontinuation of treatment with MAO inhibitors. MAO inhibitors are not prescribed within 14 days after the abolition of sertraline. Patients suffering from depression are at risk for suicidal attempts. This danger persists until remission develops. Therefore, from the beginning of treatment until the optimal clinical effect is achieved, patients should be under constant medical supervision. With the simultaneous use of the drug Serenata and drugs that have a depressant effect on the central nervous system, special care and careful monitoring of the patient’s condition are required. Side effects: On the part of the digestive system: dry mouth, decreased appetite (rarely – increased), up to anorexia, dyspeptic disorders (flatulence, nausea, vomiting, diarrhea), abdominal pain; with prolonged use in 0.8% of cases – an asymptomatic increase in the activity of transaminases in the blood serum (when the drug is discontinued, enzyme activity normalizes). From the side of the central nervous system and peripheral nervous system: drowsiness, headache, dizziness, tremor, insomnia, anxiety, agitation, hypomania, mania, gait disturbances, weakness. From the endocrine system: ejaculation disorders, decreased libido, menstrual disorders, hyperprolactinemia, galactorrhea. From the side of metabolism: increased sweating, weight loss; 0.8% (more often in elderly patients, as well as when taking diuretics or a number of other drugs) – transient hyponatremia (this side effect is associated with the syndrome of inappropriate ADH secretion). Dermatological reactions: skin redness, skin rash; rarely – erythema multiforme. Storage method: Store at a temperature not exceeding 30 degrees. Package: The carton box contains 10, 20 or 30 tablets.